Finch Therapeutics

Last updated: July 30, 2024

CEO Mark Smith
CEO Mark Smith
USA | Funding: $188.8M (+)

Website: http://finchtherapeutics.com/

Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome.